In the current scenario, the pharmaceutical market is replete with opportunities. With the growing customer base and an increasing demand of drugs for lifestyle related ailments, such as hypertension, diabetes, heart disease etc., there is a need for innovative drug launches and hence greater R&D activity in the Indian pharma sector. Both global and domestic companies have aggressive plans to tap this market. With a contributory policy-environment and the product patent law, a lot of global pharma MNCs are launching their R & D initiatives along with global pharma products.

Across the drug development value chain, a lot of work is getting offshored to both vendors and captives. However, the degree of offshoring across the value chain is varied and is most evolved and mature in the development phase of the value chain. The other components in the value chain viz. Research, Marketing & Sales, Contract Manufacturing are also gaining lot of traction and hence there is a lot of scope for offshoring by Global Pharma majors to India. The pharma offshoring development market is currently estimated at around 300 million dollars of which clinical trials constitute around 160 million dollars, CDM and Bio is at 85 million dollars and medical writing is around 10 million dollars. The rest is constituted of some other functionalities viz. site management, recruitment and others.

Get connected

Do you wish Zinnov to get in touch with you? Please mail us at help@zinnov.com

One of the other growing areas of the offshored market in pharma is the Marketing and Sales offshoring. Currently, the offshored pharma marketing and sales is around 100 million dollars with Market Intelligence and Education & training constituting more than 90% of the offshored market. The other growing niche areas are events and promotions and to a lesser degree contract structuring and related areas.  The Indian Pharma Industry is buzzing with activity. Patent laws, mergers & acquisitions, global product launches, new marketing initiatives, government initiatives are all keeping the Indian Pharma market abuzz.